JMP Securities Reaffirms “Market Outperform” Rating for Cidara Therapeutics (NASDAQ:CDTX)
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research note issued to investors on Monday,Benzinga reports. They currently have a $47.00 target price on the biotechnology company’s stock. JMP Securities’ price objective suggests a potential upside of 101.72% from the company’s […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research note issued to investors on Monday,Benzinga reports. They currently have a $47.00 target price on the biotechnology company’s stock. JMP Securities’ price objective suggests a potential upside of 101.72% from the company’s […]
